Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Apetoh, Lionel, Ghiringhelli, François, Tesniere, Antoine, Obeid, Michel, Ortiz, Carla, Criollo, Alfredo, Mignot, Grégoire, Maiuri, M Chiara +20 more·2007·Nature Medicine

Cited by (1,010)

Items 701–800 of 1,010

  1. Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA Trial
    Maria Vittoria Dieci, Valentina Guarneri, Anna Tosi, Giancarlo Bisagni, Antonino Musolino, Simon Spazzapan, Gabriella Moretti, Grazia Maria Vernaci, Gaia Griguolo, Tommaso Giarratano et al. · 2021 · Clinical Cancer Research
  2. Harnessing γδ T cells in anticancer immunotherapy
    Dalil Hannani, Yuting Ma, Takahiro Yamazaki, Julie Déchanet‐Merville, Guido Kroemer, Laurence Zitvogel · 2012 · Trends in Immunology
  3. Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses – Pre-Clinical Evidence and Ongoing Clinical Applications
    Anja Derer, Lisa Deloch, Yvonne Rubner, Rainer Fietkau, Benjamin Frey, Udo S. Gaipl · 2015 · Frontiers in Immunology
  4. Endothelial dysfunction as a complication of anti-cancer therapy
    Janée D. Terwoord, Andreas Beyer, David D. Gutterman · 2022 · Pharmacology & Therapeutics
  5. Key mechanisms involved in ionizing radiation-induced systemic effects. A current review
    Ifigeneia V. Mavragani, Danai Laskaratou, Benjamin Frey, Serge M. Candéias, Udo S. Gaipl, Katalin Lumniczky, Alexandros G. Georgakilas · 2015 · Toxicology Research
  6. p53 Autoantibodies as Potential Detection and Prognostic Biomarkers in Serous Ovarian Cancer
    Karen S. Anderson, Jessica Wong, Allison F. Vitonis, Christopher P. Crum, Patrick M. Sluss, Joshua LaBaer, Daniel William Cramer · 2010 · Cancer Epidemiology Biomarkers & Prevention
  7. Targeting pattern recognition receptors in cancer immunotherapy
    Nadège Goutagny, Yann Estornes, Uzma Ayesha Hasan, Serge Lebecque, Christophe Caux · 2012 · Targeted Oncology
  8. Autophagy protein ATG5 regulates CD36 expression and anti-tumor MHC class II antigen presentation in dendritic cells
    Dong Sun Oh, Heung Kyu Lee · 2019 · Autophagy
  9. Adjuvants for Enhancing the Immunogenicity of Whole Tumor Cell Vaccines
    Cheryl Lai-Lai Chiang, Lana Elias Kandalaft, George Coukos · 2011 · International Reviews of Immunology
  10. Cancer immunogenicity, danger signals, and DAMPs: What, when, and how?
    Abhishek Dinkarnath Garg, Aleksandra M. Dudek, Patrizia Agostinis · 2013 · BioFactors
  11. Toll-like Receptor 4 Mediates Innate Immunity to Kaposi Sarcoma Herpesvirus
    Dimitris Lagos, Richard J. Vart, Fiona Gratrix, Samantha J. Westrop, Victoria Emuss, Ping‐Pui Wong, Rebecca C. Robey, Nesrina Imami, Mark Bower, Frances M. Gotch et al. · 2008 · Cell Host & Microbe
  12. Expression of NF-κB p50 in Tumor Stroma Limits the Control of Tumors by Radiation Therapy
    Marka R. Crittenden, Benjamin Cottam, Talicia Savage, Cynthia Nguyen, Pippa Newell, Michael J. Gough · 2012 · PLoS ONE
  13. TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence
    Ilana Chefetz, Ayesha B. Alvero, Jennie C. Holmberg, Noah Lebowitz, Vinicius Craveiro, Yang Yang‐Hartwich, Gang Yin, Lisa Squillace, Marta Gurrea Soteras, Paulomi Bole Aldo et al. · 2013 · Cell Cycle
  14. Mechanisms of Immune Tolerance in Leukemia and Lymphoma
    Emily K. Curran, James K. Godfrey, Justin Paul Kline · 2017 · Trends in Immunology
  15. Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity
    Yi Huang, Huanyu Wang, Yize Hao, Hualong Lin, Menghao Dong, Jin Ye, Lei Song, Yunzhi Wang, Qingqing Li, Benjie Shan et al. · 2020 · Nature Cell Biology
  16. CD8+ Tumor-Infiltrating T Cells Are Trapped in the Tumor-Dendritic Cell Network
    Alexandre Boissonnas, Fabrice Licata, Lucie Poupel, Sébastien Jacquelin, Luc Fetler, Sophie Krumeich, Clotilde Théry, Sebastián Amigorena, Christophe Combadière · 2013 · Neoplasia
  17. Synergizing radiation therapy and immunotherapy for curing incurable cancers. Opportunities and challenges.
    James W. Hodge, Chandan Guha, Jacques Neefjes, James L. Gulley · 2008 · PubMed
  18. High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy
    Yi Luo, Yoshitomo Chihara, Kiyohide Fujimoto, Tomonori Sasahira, Masaomi Kuwada, Rina Fujiwara, Kiyomu Fujii, Hitoshi Ohmori, Hiroki Kuniyasu · 2012 · European Journal of Cancer
  19. Anti-tumor immune response induced by nanosecond pulsed streamer discharge in mice
    Kazue Mizuno, Kenta Yonetamari, Yuki Shirakawa, Taketoshi Akiyama, Ryo Ono · 2017 · Journal of Physics D Applied Physics
  20. Chemotherapy enhances vaccine‐induced antitumor immunity in melanoma patients
    Paola Nisticò, Imerio Capone, Belinda Palermo, Duilia Del Bello, Virginia Ferraresi, Federica Moschella, Eleonora Aricò, Mara Valentini, Laura Bracci, Francesco Cognetti et al. · 2008 · International Journal of Cancer
  21. Release of HMGB1 in Response to Proapoptotic Glioma Killing Strategies: Efficacy and Neurotoxicity
    Marianela Candolfi, Kader Yagiz, David S. Foulad, Gabrielle E. Alzadeh, Matthew Tesarfreund, A.K.M. Ghulam Muhammad, Mariana Puntel, Kurt M. Kroeger, Chunyan Liu, Sharon Chih Lin Lee et al. · 2009 · Clinical Cancer Research
  22. Human CD1c+ DCs are critical cellular mediators of immune responses induced by immunogenic cell death
    Stefania Di Blasio, Inge M. N. Wortel, Diede A.G. van Bladel, Laura E. de Vries, Tjitske Duiveman‐de Boer, Kuntal Worah, Nienke de Haas, Sonja I. Buschow, I. Jolanda M. de Vries, Carl Gustav Figdor et al. · 2016 · OncoImmunology
  23. Graphene quantum dots suppress proinflammatory T cell responses via autophagy-dependent induction of tolerogenic dendritic cells
    Sergej Tomić, Kristina Janjetović, Dušan Mihajlović, Marina M. Milenkovic, Tamara Kravic‐Stevovic, Zoran M Marković, Biljana M. Todorović Marković, Zdenko Špitálský, Matej Mičušík, Dragana Vučević et al. · 2017 · Biomaterials
  24. Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system
    Metamia Ciampricotti, Cheei‐Sing Hau, Chris W. Doornebal, Jos Jonkers, Karin E. de Visser · 2012 · Nature Medicine
  25. In the field: exploiting the untapped potential of immunogenic modulation by radiation in combination with immunotherapy for the treatment of cancer
    Anna R. Kwilas · 2012 · Frontiers in Oncology
  26. Immunogenic anti-cancer chemotherapy as an emerging concept
    Nicole M. Haynes, Robbert G. Van der Most, Richard Lake, Mark John Smyth · 2008 · Current Opinion in Immunology
  27. Statins, autophagy and cancer metastasis
    Jing Zhang, Zuozhang Yang, Lin Xie, Lei Xu, Da Xu, Xuefeng Liu · 2012 · The International Journal of Biochemistry & Cell Biology
  28. Antitumor Immunity Induced after α Irradiation
    Jean‐Baptiste Gorin, Jérémie Ménager, Sébastien Gouard, Catherine Maurel, Yannick Guilloux, Alain Faivre-Chauvet, Alfred Morgenstern, Frank Bruchertseifer, Michel Chérel, François Davodeau et al. · 2014 · Neoplasia
  29. Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology
    Antoine Bondue, Eloisa Arbustini, Anna Bianco, Michele Ciccarelli, Dana K. Dawson, Matteo De Rosa, Nazha Hamdani, Denise Hilfiker‐Kleiner, Benjamin Meder, Adelino Ferreira Leite-Moreira et al. · 2018 · Cardiovascular Research
  30. Sirtuins' control of autophagy and mitophagy in cancer
    Michele Aventaggiato, Enza Vernucci, Federica Barreca, Matteo Antonio Russo, Marco Tafani · 2020 · Pharmacology & Therapeutics
  31. Radiation‐induced loss of cell surface CD47 enhances immune‐mediated clearance of human papillomavirus‐positive cancer
    Daniel W. Vermeer, William Charles Spanos, Paola Drapkin Vermeer, Annie M. Bruns, Kimberly M. Lee, John H. Lee · 2013 · International Journal of Cancer
  32. The impact of radiation therapy on the antitumor immunity: Local effects and systemic consequences
    Katalin Lumniczky, Géza Sáfrány · 2013 · Cancer Letters
  33. ER calcium depletion impacts chaperone secretion, innate immunity and phagocytic uptake of cells
    L. Peters, M. Raghavan · 2011 · Journal of Immunology
  34. High-mobility group box-1 and its role in angiogenesis
    Shuai Yang, Linxinyu Xu, Tianshu Yang, Fang Wang · 2014 · Journal of Leukocyte Biology
  35. DAMP-TLR-cytokine axis dictates the fate of tumor
    Ashok Patidar, Sathishkumar Selvaraj, Aditya Yashwant Sarode, Prashant Singh Chauhan, Debprasad Chattopadhyay, Bhaskar Saha · 2017 · Cytokine
  36. Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance
    Norma Bloy, Pauline Garcia, Céline M. Laumont, Jonathan M. Pitt, Antonella Sistigu, Gautier Stoll, Takahiro Yamazaki, Éric Bonneil, Aitziber Buqué, Juliette F Humeau et al. · 2017 · Immunological Reviews
  37. Oxidative Stress-Inducing Anticancer Therapies: Taking a Closer Look at Their Immunomodulating Effects
    Jinthe Van Loenhout, Marc Peeters, Annemie Bogaerts, Evelien Smits, Christophe Deben · 2020 · Antioxidants
  38. Role of Type 1 IFNs in Antiglioma Immunosurveillance—Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans
    Mitsugu Fujita, Michael E. Scheurer, Stacy A. Decker, Heather A. McDonald, Gary Kohanbash, Edward R. Kastenhuber, Hisashi Kato, Melissa L. Bondy, John R. Ohlfest, Hideho Okada · 2010 · Clinical Cancer Research
  39. An Antitumor Immune Response Is Evoked by Partial-Volume Single-Dose Radiation in 2 Murine Models
    Ela Markovsky, Sadna Budhu, Robert M. Samstein, Hongyan Li, James Russell, Zhigang Zhang, Esther N Drill, Chloe Bodden, Qing Chen, Simon N. Powell et al. · 2018 · International Journal of Radiation Oncology*Biology*Physics
  40. Targeting innate sensing in the tumor microenvironment to improve immunotherapy
    Zhida Liu, Chuanhui Han, Yang‐Xin Fu · 2019 · Cellular and Molecular Immunology
  41. Macrophage iron homeostasis and polarization in the context of cancer
    Michaela Jung, Christina Mertens, Bernhard Brüne · 2014 · Immunobiology
  42. Toll-like receptors and B cells: functions and mechanisms
    Claire M. Buchta, Gail Abendroth Bishop · 2014 · Immunologic Research
  43. High-mobility group box 1 (HMGB1) as a master regulator of innate immunity
    Alessandra Castiglioni, Valentina Canti, Patrizia Querini Rovere, Angelo Andrea Manfredi · 2010 · Cell and Tissue Research
  44. Autophagy Induced by Conventional Chemotherapy Mediates Tumor Cell Sensitivity to Immunotherapy
    Rupal Ramakrishnan, Chun Huang, Hyun-Il Cho, Mark C. Lloyd, Joseph Johnson, Xiubao Ren, Soner Altiok, Daniel M. Sullivan, Jeffrey S. Weber, Esteban Celis et al. · 2012 · Cancer Research
  45. Shikonin-enhanced cell immunogenicity of tumor vaccine is mediated by the differential effects of DAMP components
    Tien-Jen Lin, Hsin-Ting Lin, Wei-Ting Chang, Pradeep Mitapalli. S, Pei‐Wen Hsiao, Shu‐Yi Yin, Ning‐Sun Yang · 2015 · Molecular Cancer
  46. Radiotherapy Combined with the Immunocytokine L19-IL2 Provides Long-lasting Antitumor Effects
    Catharina M.L. Zegers, Nicolle H. Rekers, Dana H.F. Quaden, Natasja G. Lieuwes, Ala Yaromina, Wilfred T.V. Germeraad, Lotte Wieten, Erik A.L. Biessen, Louis Boon, Dario Neri et al. · 2014 · Clinical Cancer Research
  47. Microenvironmental influences of apoptosis in vivo and in vitro
    Christopher D. Gregory, John D. Pound · 2010 · APOPTOSIS
  48. Toll-Like Receptors and Prostate Cancer
    Shu Zhao, Yifan Zhang, Qingyuan Zhang, Fen Wang, Dekai Zhang · 2014 · Frontiers in Immunology
  49. Chemotherapy Acts as an Adjuvant to Convert the Tumor Microenvironment into a Highly Permissive State for Vaccination-Induced Antitumor Immunity
    Tae Heung Kang, Chih-Ping Mao, Sung Yong Lee, Alexander Junxiang Chen, Ji‐Hyun Lee, Tae Woo Kim, Ronald David Alvarez, Richard B. S. Roden, Drew M. Pardoll, Chien‐Fu Hung et al. · 2013 · Cancer Research
  50. Peptide-based vaccine for cancer therapies
    Buonaguro, Luigi, Tagliamonte, Maria · 2023 · Frontiers in Immunology
  51. Cancer vaccines: current status and future directions
    Yi Zhou, Yuquan Wei, Xiaohe Tian, Xiawei Wei · 2025 · Journal of Hematology & Oncology
  52. Immunogenic Apoptotic Cell Death and Anticancer Immunity
    Peter Vandenabeele, Katrien Vandecasteele, Claus Bachert, Olga Krysko, Dmitri V. Krysko · 2016 · Advances in experimental medicine and biology
  53. Boiling Histotripsy Ablation of Renal Cell Carcinoma in the Eker Rat Promotes a Systemic Inflammatory Response
    George R. Schade, Yak-Nam Wang, Samantha DʼAndrea, Joo Ha Hwang, Wayne Conrad Liles, Tatiana D. Khokhlova · 2018 · Ultrasound in Medicine & Biology
  54. Iron Metabolism in the Tumor Microenvironment—Implications for Anti-Cancer Immune Response
    Alessandro Sacco, Anna Martina Battaglia, Cirino Botta, Ilenia Aversa, Serafina Mancuso, Francesco Saverio Costanzo, Flavia Biamonte · 2021 · Cells
  55. Chemoimmunotherapy
    Leisha A. Emens · 2010 · The Cancer Journal
  56. The iron-regulatory hormone hepcidin: A possible therapeutic target?
    Luc Rochette, Aurélie Gudjoncik, Charles Guénancia, Marianne Zeller, Yves Cottin, Catherine Vergely · 2014 · Pharmacology & Therapeutics
  57. Antitumor Immunity Triggered by Melphalan Is Potentiated by Melanoma Cell Surface–Associated Calreticulin
    Aleksandra M. Dudek-Perić, Gabriela B. Ferreira, Angelika Muchowicz, Jasper Wouters, Nicole Prada, Shaun Martin, Santeri Kiviluoto, Magdalena Winiarska, Louis Boon, Chantal Mathieu et al. · 2015 · Cancer Research
  58. Role of inflammatory infiltrates in triple negative breast cancer
    Hirofumi Matsumoto, Si‐Lin Koo, Rebecca Alexandra Dent, Puay Hoon Tan, Jabed Iqbal · 2015 · Journal of Clinical Pathology
  59. The regulation of toll-like receptor 2 by miR-143 suppresses the invasion and migration of a subset of human colorectal carcinoma cells
    Haiyan Guo, Ying Chen, Xiaobo Hu, Guanxiang Qian, Shengfang Ge, Jianjun Zhang · 2013 · Molecular Cancer
  60. Quercetin suppresses the migration and invasion in human colon cancer Caco-2 cells through regulating toll-like receptor 4/Nuclear Factor-kappa B pathway
    Yucheng Song, Mingyang Han, Xuedong Zhang · 2016 · Pharmacognosy Magazine
  61. The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade
    Takahiro Yamazaki, Jonathan M. Pitt, Marie Vétizou, Aurélien Marabelle, Chrystel Flores, Øystein Rekdal, Guido Kroemer, Laurence Zitvogel · 2016 · Cell Death and Differentiation
  62. Isolation and structure elucidation of polysaccharides from fruiting bodies of mushroom Coriolus versicolor and evaluation of their immunomodulatory effects
    Xue Zhang, Zhenyu Cai, Haoyu Mao, Pei Hu, Xiaojun Li · 2020 · International Journal of Biological Macromolecules
  63. Unboxing the molecular modalities of mutagens in cancer
    Smita Kumari, Sudhanshu Sharma, Dia Advani, Akanksha Khosla, Pravir Kumar, Rashmi K. Ambasta · 2021 · Environmental Science and Pollution Research
  64. Biomaterial‐Based In Situ Cancer Vaccines
    Bo Yang, Hua Wang · 2023 · Advanced Materials
  65. Radiation‐Induced Immunogenic Cell Death for Cancer Radioimmunotherapy
    Teng Liu, Pei Pei, Wenhao Shen, Lin Tao Hu, Kai Yang · 2023 · Small Methods
  66. Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells
    Ramon Kaneno, Galina V. Shurin, Felipe M. Kaneno, Hiam Naiditch, Jianhua Luo, Michael R. Shurin · 2011 · Cellular Oncology
  67. Mitochondrial and endoplasmic reticulum stress pathways cooperate in zearalenone-induced apoptosis of human leukemic cells
    Ratana Banjerdpongchai, Prachya Kongtawelert, Orawan Khantamat, Chantragan Srisomsap, Daranee Chokchaichamnankit, Pantipa Subhasitanont, Jisnuson Svasti · 2010 · Journal of Hematology & Oncology
  68. Concurrent radiotherapy for patients with metastatic melanoma and receiving anti-programmed-death 1 therapy: a safe and effective combination
    A. Aboudaram, A. Modesto, Léonor Chaltiel, Carlos Gomez‐Roca, Serge Boulinguez, Vincent Sibaud, Jean‐Pierre Delord, Ciprian Chira, Martine Delannes, Elizabeth Cohen‐Jonathan Moyal et al. · 2017 · Melanoma Research
  69. NK Cells and Cancer Immunoediting
    Camille Guillerey, Mark John Smyth · 2015 · Current topics in microbiology and immunology
  70. Chitosan/γ-PGA nanoparticles-based immunotherapy as adjuvant to radiotherapy in breast cancer
    Flávia Castro, Marta L. Pinto, Catarina Leite Pereira, Karine Serre, Mário Adolfo Barbosa, Karim Y. Vermaelen, Fátima Gärtner, Raquel Madeira Gonçalves, Olivier De Wever, María José Oliveira · 2020 · Biomaterials
  71. T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?
    Florian Anzengruber, Pinar Avci, Lucas Freitas de Freitas, Michael Richard Hamblin · 2015 · Photochemical & Photobiological Sciences
  72. Tumor-infiltrating CD8+ and FOXP3+ lymphocytes in triple-negative breast cancer: its correlation with pathological complete response to neoadjuvant chemotherapy
    Minoru Miyashita, Hironobu Sasano, Kentaro Tamaki, Monica S. M. Chan, Hisashi Hirakawa, Akihiko Suzuki, Hiroshi Tada, Go Watanabe, Noriko Nemoto, Saki Nakagawa et al. · 2014 · Breast Cancer Research and Treatment
  73. NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance
    Xiaoguang Li, Zhida Liu, Anli Zhang, Chuanhui Han, Aijun Shen, Lingxiang Jiang, David A. Boothman, Jian Qiao, Yang Wang, Xiumei Huang et al. · 2019 · Nature Communications
  74. Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress
    Juliette F Humeau, Allan Sauvat, Giulia Cerrato, Wei Xie, Friedemann Loos, Francesca Iannantuoni, Lucillia Bezu, Sarah Lévesque, Juliette Paillet, Jonathan G. Pol et al. · 2020 · EMBO Molecular Medicine
  75. Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity
    María Julia Lamberti, Annunziata Nigro, Fátima María Mentucci, Natalia Belén Rumie Vittar, Vincenzo Casolaro, Jessica Dal Col · 2020 · Pharmaceutics
  76. New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma
    Michele Dal Bo, Elena De Mattia, Lorena Baboçi, Silvia Mezzalira, Erika Cecchin, Yehuda G. Assaraf, Giuseppe Toffoli · 2020 · Drug Resistance Updates
  77. Resistance to Intervention: Paclitaxel in Breast Cancer
    Vipin Mohan Dan, Reji Saradha Raveendran, Sabulal Baby · 2020 · Mini-Reviews in Medicinal Chemistry
  78. Decoding immunogenic cell death from a dendritic cell perspective
    Sophie Janssens, Sofie Rennen, Patrizia Agostinis · 2023 · Immunological Reviews
  79. Emerging role of immunogenic cell death in cancer immunotherapy
    Kei‐ichiro Arimoto, Sayuri Miyauchi, Mengdan Liu, Dong‐Er Zhang · 2024 · Frontiers in Immunology
  80. Origin and Functions of Tumor-Associated Myeloid Cells (TAMCs)
    Antonio Sica, Chiara Porta, Sara Morlacchi, Stefania Banfi, Laura Strauss, Monica Rimoldi, Maria Grazia Totaro, Elena Riboldi · 2011 · Cancer Microenvironment
  81. Milk fat globule epidermal growth factor–8 blockade triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanisms
    Masahisa Jinushi, Marimo Sato, Akira Kanamoto, Akihiko Itoh, Shigenori Nagai, Shigeo Koyasu, Glenn Dranoff, Hideaki Tahara · 2009 · The Journal of Experimental Medicine
  82. The role of macrophage phenotype in regulating the response to radiation therapy
    Xiaoshan Shi, Stephen Lawrence Shiao · 2017 · Translational research
  83. The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy
    Andrew M. K. Law, Elgene Lim, Christopher John Ormandy, David Gallego‐Ortega · 2017 · Endocrine Related Cancer
  84. Immunogenic and Non-immunogenic Cell Death in the Tumor Microenvironment
    Jonathan M. Pitt, Guido Kroemer, Laurence Zitvogel · 2017 · Advances in experimental medicine and biology
  85. Selective ablation of cancer cells with low intensity pulsed ultrasound
    David Reza Mittelstein, Jian Ye, Erika F. Schibber, Ankita Roychoudhury, Leyre Troyas Martinez, Mohammad Houman Fekrazad, M. Ortíz, Peter P. Lee, Mikhail G. Shapiro, Morteza Gharib · 2020 · Applied Physics Letters
  86. Role of Neutrophils and Myeloid-Derived Suppressor Cells in Glioma Progression and Treatment Resistance
    Sabbir Khan, Sandeep Mittal, Kain McGee, Kristin D. Alfaro-Munoz, Nazanin Majd, Veerakumar Balasubramaniyan, John de Groot · 2020 · International Journal of Molecular Sciences
  87. Prodrug‐Based Versatile Nanomedicine for Enhancing Cancer Immunotherapy by Increasing Immunogenic Cell Death
    Shuang Bai, Leilei Yang, Yajun Wang, Tian Zhang, Lvqin Fu, Shao‐Chen Yang, Shu‐Cheng Wan, Shuo Wang, Die Jia, Baosheng Li et al. · 2020 · Small
  88. Radiation Therapy and the In Situ Vaccination Approach
    Encouse B. Golden, Ariel E. E. Marciscano, Silvia Chiara Formenti · 2020 · International Journal of Radiation Oncology*Biology*Physics
  89. Carbon ion radiotherapy triggers immunogenic cell death and sensitizes melanoma to anti-PD-1 therapy in mice
    Heng Zhou, Chen Tu, Pengfei Yang, Jin Li, Oliver Kepp, Haining Li, Liying Zhang, Lixin Zhang, Yang Zhao, Tianyi Zhang et al. · 2022 · OncoImmunology
  90. Radiation-inducible Immunotherapy for Cancer: Senescent Tumor Cells as a Cancer Vaccine
    Yuru Meng, Elena V. Efimova, Khaled Hamzeh, Thomas E. Darga, Helena J. Mauceri, Yang‐Xin Fu, Stephen J. Kron, Ralph R. Weichselbaum · 2012 · Molecular Therapy
  91. Biological mechanism and clinical effect of protein-bound polysaccharide K (KRESTIN®): review of development and future perspectives
    Yoshihiko Maehara, Shunichi Tsujitani, Hiroshi Saeki, Eiji Oki, Keiji Yoshinaga, Yasunori Emi, Masaru Morita, Shunji Kohnoe, Yoshihiro Kakeji, Tokujiro Yano et al. · 2011 · Surgery Today
  92. Route of Administration of the TLR9 Agonist CpG Critically Determines the Efficacy of Cancer Immunotherapy in Mice
    Stefan Nierkens, Martijn H. den Brok, Thijs Roelofsen, Jori A. L. Wagenaars, Carl Gustav Figdor, Theo J. M. Ruers, Gosse J. Adema · 2009 · PLoS ONE
  93. Phase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients
    Hisae Iinuma, Ryoji Fukushima, Tsuyoshi Inaba, Junko Tamura, Taisuke Inoue, Etsushi Ogawa, Masahiro Horikawa, Yoshibumi Ikeda, Noriyuki Matsutani, Kazuyoshi Takeda et al. · 2014 · Journal of Translational Medicine
  94. High-Mobility Group Box-1 Mediates Toll-Like Receptor 4–Dependent Angiogenesis
    Qing Lin, Xiao Ping Yang, Dan Fang, Xiangrong Ren, Hongyan Zhou, Jiazhu Fang, Xialin Liu, Shiyou Zhou, Wen Feng, Xiaohong Yao et al. · 2011 · Arteriosclerosis Thrombosis and Vascular Biology
  95. The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases
    Mao Wang, Alex G. Gauthier, Lee-Anne Daley, Katelyn Dial, Jiaqi Wu, Joanna Woo, Mosi Lin, Charles R. Ashby, Lin L. Mantell · 2019 · Antioxidants and Redox Signaling
  96. Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations
    Madyson Colton, Eleanor J. Cheadle, Jamie Honeychurch, Tim Illidge · 2020 · Radiation Oncology
  97. Regulatory T Cells in Radiotherapeutic Responses
    Dörthe Schaue, Michael W. Xie, Josephine A. Ratikan, William H. McBride · 2012 · Frontiers in Oncology
  98. Muscle Atrophy in Response to Cytotoxic Chemotherapy Is Dependent on Intact Glucocorticoid Signaling in Skeletal Muscle
    Theodore P. Braun, Marek Szumowski, Peter R. Levasseur, Aaron J. Grossberg, Xinxia Zhu, Anupriya Agarwal, Daniel L. Marks · 2014 · PLoS ONE
  99. Regulated cell death pathways: New twists in modulation of BCL2 family function
    Nidhish Sasi, Misun Hwang, Jerry Jeff Jaboin, Ildiko Csiki, Jiahong Lu · 2009 · Molecular Cancer Therapeutics
  100. Microbiota–drug interactions: Impact on metabolism and efficacy of therapeutics
    Ellen M. Wilkinson, Zehra Esra Ilhan, Melissa M. Herbst‐Kralovetz · 2018 · Maturitas